Evidence map›Paper›PMID 25210784›Full record

ArticlePloS one2014

DJ-1 interacts with and regulates paraoxonase-2, an enzyme critical for neuronal survival in response to oxidative stress.

Mohammad Parsanejad, Noam Bourquard, Dianbo Qu, Yi Zhang, En Huang, Maxime W C Rousseaux, Hossein Aleyasin, Isabella Irrcher, Steve Callaghan, Dominique C Vaillant and 6 more

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Paraoxonase 2 as a target for aging-related diseases.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2026
    Review
  2. Oxidative Stress in Brain Function.Antioxidants (Basel, Switzerland) · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Paraoxonases at the Heart of Neurological Disorders.International journal of molecular sciences · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The cell biology of Parkinson's disease.The Journal of cell biology · 2021
    Review
  15. Review
  16. Human Paraoxonase-2 (PON2): Protein Functions and Modulation.Antioxidants (Basel, Switzerland) · 2021
    Review
  17. Parkinson's disease treatment: past, present, and future.Journal of neural transmission (Vienna, Austria : 1996) · 2020
    Review
  18. Article
  19. Role of DJ-1 in the mechanism of pathogenesis of Parkinson's disease.Journal of bioenergetics and biomembranes · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Mohammad ParsanejadDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Noam BourquardDepartment of Medicine and Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at Univeristy of California Los Angeles, Los Angeles, California, United States of America.
Dianbo QuDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Yi ZhangDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.
En HuangDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Maxime W C RousseauxDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America.
Hossein AleyasinDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada; Fishberg Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Isabella IrrcherDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Ophthalmology, Queen's University, Kingston, Ontario, Canada.
Steve CallaghanDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Dominique C VaillantDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Raymond H KimThe Campbell Family Institute for Breast Cancer Research, Toronto, Ontario, Canada.
Ruth S SlackDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Tak W MakThe Campbell Family Institute for Breast Cancer Research, Toronto, Ontario, Canada.
Srinivasa T ReddyDepartment of Medicine and Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at Univeristy of California Los Angeles, Los Angeles, California, United States of America.
Daniel FigeysOttawa Institute of Systems Biology (OISB), University of Ottawa, Ottawa, Ontario, Canada.
David S ParkDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Cogno-Mechatronics Engineering, Pusan National University, Busan, Korea.

Funding

The role of PON2 and PON3 proteins in AtherosclerosisR01HL071776 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI REDDY, SRINIVASA T. · 2003 to 2017
$4.8M
CIHRNHLBI NIH HHS 1R01HL71776NHLBI NIH HHS R01 HL071776
6 · The paper itself

Abstract

Loss-of-function mutations in DJ-1 (PARK7) gene account for about 1% of all familial Parkinson's disease (PD). While its physiological function(s) are not completely clear, DJ-1 protects neurons against oxidative stress in both in vitro and in vivo models of PD. The molecular mechanism(s) through which DJ-1 alleviates oxidative stress-mediated damage remains elusive. In this study, we identified Paraoxonase-2 (PON2) as an interacting target of DJ-1. PON2 activity is elevated in response to oxidative stress and DJ-1 is crucial for this response. Importantly, we showed that PON2 deficiency hypersensitizes neurons to oxidative stress induced by MPP+ (1-methyl-4-phenylpyridinium). Conversely, over-expression of PON2 protects neurons in this death paradigm. Interestingly, PON2 effectively rescues DJ-1 deficiency-mediated hypersensitivity to oxidative stress. Taken together, our data suggest a model by which DJ-1 exerts its antioxidant activities, at least partly through regulation of PON2.

Indexed as

AnimalsAntioxidantsApoptosisAryldialkylphosphataseCell SurvivalGene Expression RegulationHEK293 CellsHumansIntracellular Signaling Peptides and ProteinsMiceMitochondriaNeuronsOncogene ProteinsOxidative StressParkinson DiseaseProtein Deglycase DJ-1AntioxidantsAryldialkylphosphataseIntracellular Signaling Peptides and ProteinsOncogene ProteinsPARK7 protein, humanProtein Deglycase DJ-1

Identifiers

PMID25210784
PMCPMC4161380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.